Fulltext

Off-label use of repurposed ivermectin for SARS-CoV-2 infection should be banned by authorities unless efficacy is proven

Finsterer J 1

Affiliations 

  • 1 MD, PhD, Neurology and Neurophysiology Center, Postfach 20, Vienna, Austria. Email: fifigs1@yahoo.de
Malays Fam Physician, 2024;19:41.
PMID: 39156229 DOI: 10.51866/lte.664

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications